Hiv Epi Fact Sheet March 2025
Hiv Epi Fact Sheet March 2025
Fig 2. Global trends in people acquiring HIV and people dying from HIV-related causes,
2010–2023 and projections to 2030
2 000 000
1 500 000
Shaded areas:
gaps towards achieving
2025 and 2030 targets
1 000 000
2025 2030
targets targets
500 000
0
2010 2023 2025 2030
Annual number of people newly infected Annual number of people dying from HIV-related
with HIV – with projections reaching 2025 causes – with projections reaching 2025 and 2030
and 2030 targets under the strategy targets under the strategy
Projected annual number of people newly Projected annual number of people dying
infected with HIV – maintaining current level from HIV-related causes – maintaining
of services current level of services
Note: The United Nations global targets for 2025 are twinfold: reducing the number of people acquiring HIV to less than 370 000 and reducing the
number of HIV-related deaths to less than 250 000. To end AIDS as a public health threat by 2030, the targets are a 90% reduction of the number of
people acquiring HIV and dying from HIV using 2010 as the baseline.
Sources: Avenir Health using 2025 targets and UNAIDS/WHO epidemiological estimates, 2024.
a
lobal health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health
G
Organization; 2022 (https://apps.who.int/iris/handle/10665/360348, accessed 7 July 2024).
2
European Region
WHO regional data
• An estimated 3.1 million [2.8–3.4 million] people
were living with HIV in 2023, of which 62% [49–71%]
African Region were receiving treatment. An estimated 1.9 million
• An estimated 26.0 million [23.6–28.8 million] people people were receiving antiretroviral therapy in 2023.
were living with HIV in 2023, of which 90% [72–>98%] • An estimated 160 000 [140 000–190 000] people
knew their status, 82% [65–95%] were receiving acquired HIV in 2023; and the number of people
treatment and 76% [69–85%] had suppressed acquiring HIV increased to 0.18 [0.15–0.21] per
viral loads. An estimated 21.3 million people were 1000 uninfected population in 2023, from 0.17
receiving antiretroviral therapy in 2023. [0.14–0.20] in 2010.
• An estimated 640 000 [490 000–860 000] people • 49 000 [38 000–60 000] deaths were attributed to
acquired HIV in 2023; and the number of people HIV-related causes in 2023, an increase of 27%
acquiring HIV decreased to 0.55 [0.41–0.73] per 1000 from 2010.
uninfected population in 2023 from 1.76 [1.32–2.34]
in 2010. Eastern Mediterranean Region
• 390 000 [310 000–490 000] deaths were attributed • An estimated 530 000 [440 000–700 000] people
to HIV-related causes in 2023, a decrease of 56% were living with HIV in 2023, of which 38% [28–52%]
from 2010. knew their status, 28% [20–38%] were receiving
treatment and 24% [20–32%] had suppressed viral
Region of the Americas loads. An estimated 150 000 people were receiving
• An estimated 4.0 million [3.5–4.5 million] people antiretroviral therapy in 2023.
were living with HIV in 2023, of which 89% [68–>98%] • An estimated 67 000 [53 000–96 000] people acquired
knew their status, 72% [55–85%] were receiving HIV in 2023; and the number of people acquiring
treatment and 66% [58–75%] had suppressed viral HIV remained stable at <0.1 [<0.1–0.12] per 1000
loads. An estimated 2.9 million people were receiving uninfected population in 2023 from <0.1 [<0.1–<0.1]
antiretroviral therapy in 2023. in 2010.
• An estimated 160 000 [130 000–210 000] people • 20 000 [15 000–29 000] deaths were attributed to
acquired HIV in 2023; and the number of people HIV-related causes in 2023, an increase of 69%
acquiring HIV decreased to 0.16 [0.13–0.20] per from 2010.
1000 uninfected population in 2023 from 0.18
[0.15–0.23] in 2010. Western Pacific Region
• 44 000 [32 000–60 000] deaths were attributed • An estimated 2.3 million [2.2–2.4 million] people
to HIV-related causes in 2023, a decrease of 35% were living with HIV in 2023, of which 85% [70–93%]
from 2010. knew their status, 76% [63–83%] were receiving
treatment and 73% [69–77%] had suppressed
South-East Asian Region viral loads. An estimated 1.8 million people
• An estimated 4.0 million [3.5–4.8 million] people were receiving antiretroviral therapy in 2023.
were living with HIV in 2023, of which 78% [60–96%] • An estimated 140 000 [130 000–150 000] people
knew their status, 66% [51–81%] were receiving acquired HIV in 2023; and the number of people
treatment and 64% [56–76%] had suppressed acquiring HIV remained stable at <0.1 [<0.1–<0.1]
viral loads. An estimated 2.7 million people per 1000 uninfected population in 2023 from <0.1
were receiving antiretroviral therapy in 2023. [<0.1–<0.1] in 2010.
• An estimated 120 000 [91 000–160 000] people • 53 000 [42 000–65 000] deaths were attributed to
acquired HIV in 2023; and the number of people HIV-related causes in 2023, a decrease of 15% from
acquiring HIV decreased to <0.1 [<0.1–<0.1] per 2010 but an increase of 2.9% compared with 2022.
1000 uninfected population in 2023 from 0.12
[<0.1–0.17] in 2010.
• 83 000 [61 000–110 000] deaths were attributed
to HIV-related causes in 2023, a decrease of 65%
from 2010.
3
Fig 3. Progress towards achieving the HIV testing, treatment and viral load suppression
cascades targets among people living with HIV, globally and by WHO region, 2023
100%
93
90%
90 89
86
84 85
80% 82
79 80
77 78
76 76
74 73
70% 72 72
68
66 66
64
60% 62
50%
40%
38
30%
28
24
20%
10%
0%
Global African Eastern and Western Region South-East European Eastern Western
Region Southern and Central of the Asia Region Region Mediterranean Pacific
Africa Africa Americas Region Region
Percentage of people who know their status among people Gap to reach the first 95‒90‒86 treatment cascade target
living with HIV Gap to reach the second 95‒90‒86 treatment cascade target
Percentage of people on ART among people living with HIV Gap to reach the third 95‒90‒86 treatment cascade target
Percentage of people with suppressed viral load among
people living with HIV
4
Table 1. Estimated number of people living with HIV, all ages, 2010, 2022 and 2023
5
Table 2. People living with HIV receiving antiretroviral therapy and antiretroviral therapy coverage, all ages, 2010, 2022 and 2023
WHO region People living with HIV receiving antiretroviral therapy Estimated antiretroviral therapy coverage among people living with HIV (%)
6
Table 3. Estimated number of people acquiring HIV and infection rate, all ages, 2010, 2022 and 2023
WHO region People acquiring HIV New HIV infections (per 1000 uninfected population)
Global 2 100 000 1 400 000 1 300 000 0.32 0.17 0.17
[1 700 000–2 700 000] [1 100 000–1 700 000] [1 000 000–1 700 000] [0.25–0.40] [0.14–0.22] [0.13–0.21]
African Region 1 500 000 700 000 640 000 1.76 0.61 0.55
[1 100 000–2 000 000] [540 000–940 000] [490 000–860 000] [1.32–2.34] [0.46–0.82] [0.41–0.73]
Eastern and 1 100 000 480 000 440 000 3.21 1.03 0.92
Southern Africa [860 000–1 400 000] [380 000–620 000] [350 000–560 000] [2.52–4.14] [0.81–1.33] [0.72–1.18]
Western and 380 000 220 000 210 000 0.77 0.33 0.30
Central Africa [260 000–560 000] [150 000–330 000] [140 000–300 000] [0.52–1.11] [0.22–0.47] [0.20–0.43]
Region of the Americas 170 000 170 000 160 000 0.18 0.16 0.16
[140 000–210 000] [130 000–210 000] [130 000–210 000] [0.15–0.23] [0.13–0.20] [0.13–0.20]
South-East Asia Region 210 000 130 000 120 000 0.12 <0.1 <0.1
[160 000–290 000] [98 000–180 000] [91 000–160 000] [<0.1–0.17] [<0.1–<0.1] [<0.1–<0.1]
European Region 150 000 160 000 160 000 0.17 0.18 0.18
[130 000–170 000] [140 000–190 000] [140 000–190 000] [0.14–0.20] [0.15–0.21] [0.15–0.21]
Western Pacific Region 120 000 140 000 140 000 <0.1 <0.1 <0.1
[110 000–130 000] [130 000–150 000] [130 000–150 000] [<0.1–<0.1] [<0.1–<0.1] [<0.1–<0.1]
7
Table 4. Estimated number of HIV-related deaths, all ages, 2010, 2022 and 2023